Press Release

SSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Avexitide Program Assets to Amylyx Pharmaceuticals

SSG Advises CPL in the Sale to Aterian Investment Partners

SSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Zokinvy® Program Assets to Sentynl Therapeutics, Inc.

SSG Advises the Chapter 7 Trustee of ContraFect Corporation in the Sale of Substantially All Intellectual Property Assets to Aurobac Therapeutics SAS

Teresa C. Kohl Recognized with the M&A Advisor’s 2024 Leadership Award